Leaflet PAGLITAZ 15mg tablets


Indicated for: type 2 diabetes mellitus

Route of administration: oral

Substance: pioglitazone (thiazolidinedione antidiabetic)

ATC: A10BG03 (Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Thiazolidinediones)

Pioglitazone is a medication used for the treatment of type 2 diabetes. It belongs to the thiazolidinedione class and works by increasing the sensitivity of cells to insulin, helping to control blood glucose levels.

The medication is taken orally, usually once daily, and should be used as directed by your doctor. It is important to combine the treatment with a healthy diet and regular exercise to achieve the best results.

Side effects may include weight gain, fluid retention, headache, or, in rare cases, heart failure or bone fractures.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as heart or liver diseases, to ensure the safe use of pioglitazone.

General data about PAGLITAZ 15mg

  • Substance: pioglitazone
  • Date of last drug list: 01-07-2013
  • Commercial code: W58500001
  • Concentration: 15mg
  • Pharmaceutical form: tablets
  • Quantity: 14
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for pioglitazone

  • 15mg
  • 30mg
  • 45mg